175 related articles for article (PubMed ID: 11719446)
1. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis.
Chun YJ; Kim S; Kim D; Lee SK; Guengerich FP
Cancer Res; 2001 Nov; 61(22):8164-70. PubMed ID: 11719446
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin.
Chun YJ; Ryu SY; Jeong TC; Kim MY
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):389-93. PubMed ID: 11259321
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene.
Chun YJ; Oh YK; Kim BJ; Kim D; Kim SS; Choi HK; Kim MY
Toxicol Lett; 2009 Aug; 189(1):84-9. PubMed ID: 19463925
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
Chun YJ; Kim MY; Guengerich FP
Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
[TBL] [Abstract][Full Text] [Related]
5. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of recombinant human cytochrome p-450 1A1 by pentamethoxystilbene.
Lee SK; Kim Y; Kim MY; Chun YJ; Kim S
J Toxicol Environ Health A; 2004 Dec; 67(23-24):1987-2000. PubMed ID: 15513897
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
Shimada T; Guengerich FP
Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase.
Shimada T; Gillam EM; Oda Y; Tsumura F; Sutter TR; Guengerich FP; Inoue K
Chem Res Toxicol; 1999 Jul; 12(7):623-9. PubMed ID: 10409402
[TBL] [Abstract][Full Text] [Related]
9. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
[TBL] [Abstract][Full Text] [Related]
10. Potent inhibition of human cytochrome P450 1 enzymes by dimethoxyphenylvinyl thiophene.
Lee SK; Kim Y; Kim MY; Kim S; Chun YJ
Arch Pharm Res; 2004 Feb; 27(2):199-205. PubMed ID: 15022723
[TBL] [Abstract][Full Text] [Related]
11. Roles of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cytochrome P450 1B1 variants in Escherichia coli.
Shimada T; Tsumura F; Gillam EM; Guengerich FP; Inoue K
Protein Expr Purif; 2000 Oct; 20(1):73-80. PubMed ID: 11035953
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human cytochrome P450 1B1 expression in Escherichia coli.
Shimada T; Wunsch RM; Hanna IH; Sutter TR; Guengerich FP; Gillam EM
Arch Biochem Biophys; 1998 Sep; 357(1):111-20. PubMed ID: 9721189
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
Yao HT; Chang YW; Lan SJ; Yeh TK
Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
[TBL] [Abstract][Full Text] [Related]
16. Modulation of human cytochrome P450 1B1 expression by 2,4,3',5'-tetramethoxystilbene.
Chun YJ; Lee SK; Kim MY
Drug Metab Dispos; 2005 Dec; 33(12):1771-6. PubMed ID: 16120791
[TBL] [Abstract][Full Text] [Related]
17. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
Shimada T; Yamazaki H; Foroozesh M; Hopkins NE; Alworth WL; Guengerich FP
Chem Res Toxicol; 1998 Sep; 11(9):1048-56. PubMed ID: 9760279
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
19. Effects of bioflavonoids on hepatic P450 activities.
Obermeier MT; White RE; Yang CS
Xenobiotica; 1995 Jun; 25(6):575-84. PubMed ID: 7483658
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
